Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML study group Ulm

769

  • Fröhling, S.
  • Schlenk, R. F.
  • Breitruck, J.
  • Benner, A.
  • Kreitmeier, S.
  • Tobis, K.
  • Döhner, H.
  • Döhner, K.

  • (1)University Hospital of Ulm, Germany; (2)German Cancer Research Center, Heidelberg, Germany

Onkologie 25:p 218, October 2002.
Copyright © 2002 S. Karger AG, Basel
View full text|Download PDF